(Q31095975)

English

Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

hospitalization

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27177784%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27177784%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27177784%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Darren M. Ashcroft

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27177784%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

D T Steinke

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27177784%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

13 May 2016

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27177784%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27177784%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27177784%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

916-924

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27177784%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Blood pressure, lipids and glucose in type 2 diabetes: how low should we go? Re-discovering personalized care

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: an observational study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Differential cardiovascular outcomes after dipeptidyl peptidase-4 inhibitor, sulfonylurea, and pioglitazone therapy, all in combination with metformin, for type 2 diabetes: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Data Resource Profile: Clinical Practice Research Datalink (CPRD)

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Validity of diagnostic coding within the General Practice Research Database: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

ClinicalCodes: an online clinical codes repository to improve the validity and reproducibility of research using electronic medical records

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Comparing pioglitazone to insulin with respect to cancer, cardiovascular and bone fracture endpoints, using propensity score weights

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE).

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12692

21 January 2018

Identifiers

10.1111/DOM.12692

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27177784%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27177784%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31095975&oldid=1603603179"